{"nct_id":"NCT02453594","title":"Study of Pembrolizumab (MK-3475) in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma (MK-3475-087/KEYNOTE-087)","status":"COMPLETED","status_verified_date":"2024-10","start_date":"2015-06-10","start_date_type":"ACTUAL","primary_completion_date":"2023-09-18","primary_completion_date_type":"ACTUAL","completion_date":"2023-09-18","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["MRK"]}